Director Speak

Home > Director Speak

From the Director Speak

It all started with a vision to create a Global Pharmaceutical company. We are working towards this goal with utmost enthusiasm and commitment. As a result, Nixi Laboratories has successfully established itself as a trustworthy name in the pharmaceutical world.
These envisioned words of Mr. Sanjeev Kumar, our Chairman and Managing Director, Mr. Paresh Bagadia ( Director ), Mr. Harmanpreet Singh ( M.D ) reflect the extreme passion and enthusiasm that drives the organization.

Nixi Laboratories, headquartered at Mumbai (India) is a global pharmaceutical company. We are actively engaged in R&D and offer CRAMS to global pharmaceutical companies.

Our Focus Markets

We have a special focus towards exports markets like  Vietnam, Myanmar, Bhutan, Yemen, Uzbekistan Istanbul, Philippines,  Nigeria, Tajikistan, Nepal,  Uzbekistan and Ethiopia. Through ongoing research and product development, we have been able to grow from strength-to-strength in these markets and are taking giant strides each day! Having established our presence in these markets, we are now expanding our focus towards emerging markets where we have over 300+ approved products and 280+ products export approvals.

Our Capabilities

Our formulation manufacturing plant at Haryana, has state-of-the-art facilities and is specially designed to meet the global statutory requirements. This plant is FDA approved and seeking approvals from esteemed organizations such as Philippines,  Nigeria, Tajikistan, Nepal, Vietnam, Myanmar, Bhutan, Yemen, Uzbekistan . We also have a WHO GMP certificate. This factory has the largest Liquid and dry injections manufacturing facility in India. This is a 100% EOU. To strengthen our global efforts, a full-fledged R&D center has been set up along with the manufacturing facility at Haryana.

Way Ahead

There are changes, challenges and opportunities that lie ahead for Nixi Laboratories. In order to seize these opportunities, we are putting forth a concerted and systematic effort powered by expert and professional planning and implementation. We continue to acquire and develop winning strengths and capabilities in our drive towards becoming a research-driven Indian pharmaceutical company operating on a global scale.
The past few years, we have gained momentum in each of these thrust areas with important gains in marketing, globalization and research – especially in terms of creating essential capabilities for the challenges ahead. With this, all of us are committed to explore our true potential and face the challenges on our way to attain important milestones.
We know that a lot remains to be done. Our early success has given us the confidence, respect, and credibility. Real work has started; we will see the fruits of the same in the months and years to come.